Israel Active

I featured previously Israeli startup Zebra Medical Vision which uses Artificial Intelligence to analyze the results of medical scans. Zebra is offering all its algorithms for $1 per scan. Now all hospitals can afford to test patients for osteoporosis, cardiac disease, liver disease, early cancer etc.

I featured previously the Israeli-developed MyMDBand QR-coded wristband that provides paramedics with a patient’s vital medical data. Israeli Asaf Luxembourg, just won a WeWork Creator Award for it.  United Hatzalah have distributed thousands of MyMDBands to the elderly.

I reported previously that the minimally invasive RENOVA leg implant from Israel’s BlueWind to treat Overactive Bladder (OAB) had been granted European approval. Recent trials show that device gave over 50% improvement to 71% of participants.

I’ve reported previously on Israeli biotech Pluristem’s PLX stem cell treatment for many life-threatening conditions. Recent lab trials with modified PLX cells showed significant inhibitory effect on various lines of breast, colorectal, kidney, liver, lung, muscle and skin cancers.

I reported previously on the US takeover of Israeli biotech Kite for $12 billion. The US FDA has now approved Kite’s Yescarta treatment for adults with relapsed or refractory large B-cell lymphoma. The treatment uses Israeli-developed CAR-T therapy from the patient’s own T-cells.

Following a Priority Review, the US FDA has approved Israel TEVA’s Leukemia treatment, TRISENOX® (arsenic trioxidec). Trisenox is to be used in combination with tretinoin for treatment of recently-diagnosed low-risk adults with acute promyelocytic leukemia (APL).

Israel’s Laniado hospital used groundbreaking stem cell treatment from Israel’s BioGenCell to save amputating the legs of five diabetic patients with poor circulation. Stem cells from the patients’ blood injected into their leg muscles grew new blood vessels to bypass blockages.

50 doctors at Haifa’s Rambam Medical Center have performed “the impossible”. They conducted three highly complex operations to save a 2kg premature baby that was born with a rare “teratoma” – a 1kg tumor attached to her brain, jaw, neck, chest, airways and blood vessels.

Israel’s STS Medical has received regulatory clearance from the US FDA for its composite sinus stent. Following nasal surgery (e.g. on sinusitis and allergic rhinitis sufferers where other treatments have not worked) the stent keeps the nasal airways open to allow the sinus tissue to heal.

Israel’s Check-cap has just received the CE Mark for its C-Scan ingestible capsule for preparation-free, colorectal cancer screening. The capsule uses low-dose X-rays to obtain 3D images of the colon whilst allowing patients to go about their normal daily routines.